InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
T+90 hit rate
56%
T+90 mean return
-2.8%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by GUGGENHIME ANDREW, Chief Financial Officer. Insider active across 1 company, notably Vaxcyte, Inc.. Cumulatively, 43 disclosures have been logged. Split: 0 buy · 1 sell. History available since 18 November 2021. The latest transaction was disclosed on 7 April 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations43 total
10,000 sharesCommon StockSEC:0001230724-26-000010:0
10,000 sharesCommon StockSEC:0001230724-26-000010:1
4,777 shares@ US$20.933.6% of flowCommon StockSEC:0001649094-25-000049:0
22,761 shares0Common StockSEC:0001649094-25-000043:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-25-000014:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-25-000008:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-24-000126:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-24-000112:0
19,108 shares@ US$20.9314.5% of flowCommon StockSEC:0001649094-24-000084:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-24-000082:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001649094-24-000071:0
6,337 shares@ US$110.1524.9% of flowCommon StockSEC:0001649094-24-000065:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001649094-24-000054:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001649094-24-000038:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-24-000018:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001415889-24-014108:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001415889-24-011322:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001415889-24-008745:0
20,000 shares0Common StockSEC:0001415889-24-006473:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001415889-24-004810:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001415889-24-001589:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001209191-23-059346:0
14,000 shares@ US$5.352.7% of flowCommon StockSEC:0001209191-23-058943:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001209191-23-056486:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001209191-23-053251:0
25 of 43 declarations
About GUGGENHIME ANDREW
GUGGENHIME ANDREW is the President and Chief Financial Officer of Vaxcyte, Inc. He oversees the company's financial management, including budgeting and performance analysis.
